{"id":3412,"date":"2019-05-29T17:59:41","date_gmt":"2019-05-29T17:59:41","guid":{"rendered":"https:\/\/omnilegalgroup.com\/blog\/?p=3412"},"modified":"2020-10-23T09:21:41","modified_gmt":"2020-10-23T09:21:41","slug":"can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products","status":"publish","type":"post","link":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/","title":{"rendered":"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0"},"content":{"rendered":"\r\n<ul class=\"wp-block-gallery columns-1 is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\">\r\n<li class=\"blocks-gallery-item\">\r\n<figure><img loading=\"lazy\" decoding=\"async\" width=\"799\" height=\"1024\" class=\"wp-image-3413\" src=\"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-799x1024.jpg\" alt=\"\" data-id=\"3413\" data-link=\"https:\/\/omnilegalgroup.com\/blog\/?attachment_id=3413\" srcset=\"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-799x1024.jpg 799w, https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-117x150.jpg 117w, https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-234x300.jpg 234w, https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-768x985.jpg 768w, https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-680x872.jpg 680w, https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped.jpg 1382w\" sizes=\"auto, (max-width: 799px) 100vw, 799px\" \/><\/figure>\r\n<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p>The U.S. District Court for the Southern District of New York issued its final consent judgment to the settlement agreement between GSK and Laclede, Inc. on Friday, May 24, 2019.\u00a0\u00a0By issuing its final consent judgment, the U.S. District Court for the Southern District of New York agreed to the settlement agreement between GSK and Laclede concluding the trademark infringement action over the BIOTENE trademarks. \u00a0 \u00a0 \u00a0 \u00a0<\/p>\r\n\r\n\r\n\r\n<p>Multinational pharmaceutical company, GSK, filed intellectual property claims against Laclede, a pharmaceutical company that researches, develops, and manufactures a variety of over-the-counter and prescription medications, after a $170 million dollar purchase of Laclede\u2019s intellectual property that included various BIOTENE trademarks relating to eighteen products of Laclede\u2019s \u201cBIOTENE\u201d dental product line used for treating dry mouth.\u00a0 The BIOTENE dental product line consists of over-the counter products including mouthwashes and toothpastes used for treating dry mouth.\u00a0\u00a0After purchasing the rights to the BIOTENE dental product line, GSK invested in advertising and promoting the BIOTENE product line.\u00a0\u00a0In 2017, GSK spent over $20 million advertising and promoting the BIOTENE product line.\u00a0\u00a0In addition to investing in advertisements and promotion for the BIOTENE product line,\u00a0GSK also reformulated the BIOTENE dental product line.<\/p>\r\n\r\n\r\n\r\n<p>Three years after transferring all of the intellectual property rights including the \u201cBIOTENE\u201d trademark, Laclede introduced its SALIVEA dental product line.\u00a0 The SALIVEA dental product line was a direct competitor with the BIOTENE dental product line, and included products such as mouthwash and toothpaste used for treating dry mouth.\u00a0 Court documents indicate that Laclede sent \u201capproximately 100,000 mailers\u2026to healthcare professionals and others\u201d and advertised the SALIVEA product line through its website.\u00a0 Laclede\u2019s advertisements listed trademarked phrases such as \u201c#1 brand for dry mouth\u201d, \u201cORIGINAL Biotene Formula\u201d and featured trademarked logos such as the \u201cblue-and-red BIOTENE logo\u201d and the \u201cBIOTENE droplet\u201d.\u00a0 On June 4, 2018, GSK filed its trademark infringement claims against Laclede and its shareholders, Michael Pellico and Stephen Pellico, for using various BIOTENE trademarks.<\/p>\r\n\r\n\r\n\r\n<p>A trademark is any word, name, symbol, and or device used by a trademark holder to identify and distinguish the trademark holder\u2019s products from products manufactured and sold by others.\u00a0 In order for a trademark holder to register a trademark, a trademark must distinguish the trademark holder\u2019s products from the products of others.\u00a0 Once a trademark holder registers a trademark with the Patent and Trademark Office,\u00a0 a trademark holder holds rights to the trademark in the U.S. if the trademark holder uses the trademark in commerce.\u00a0 A trademark holder maintains its rights in its trademark as long as the trademark holder uses the trademark to designate the origin of a product.<\/p>\r\n\r\n\r\n\r\n<p>Trademark infringement refers to the unauthorized use of a trademark in connection with the sale, offering for sale, distribution, or advertising of any goods where such use is likely to cause confusion.\u00a0 A trademark holder may seek remedies in federal court for infringement under Section 32 of the Lanham Act.\u00a0 The Lanham Act is a federal statute that protects registered trademarks and that allows a trademark holder to file a civil action against an infringer for trademark infringement.\u00a0 In order to prevail in a trademark infringement action under Section 32 of the Lanham Act, a trademark holder, \u00a0\u201cmust establish that the trademark holder possesses a valid, legally protectable trademark, and that the infringer\u2019s subsequent use of a similar mark is likely to create confusion as to the origin of the product at issue.\u201d\u00a0 Whether the infringer\u2019s subsequent use of a similar mark is likely to create confusion as to the origin of the product at issue is guided by an eight factor balancing test first articulated by .\u00a0 The eight factors include: (1) the strength of the trademark; (2) the similarity of the marks; (3) the proximity of the productions and their competitiveness with one another; (4) evidence that the senior user may \u201cbridge the gap\u201d by developing a product for sale in the market of the alleged infringer\u2019s product; (5) evidence of actual consumer confusion; (6) evidence that the imitative mark was adopted in bad faith; (7) the respective quality of the products; and (8) the sophistication (or lack thereof) of consumers in the relevant market. \u00a0<\/p>\r\n\r\n\r\n\r\n<p>In its January 23, 2019 Opinion and Order issued by United States District Judge Jesse M. Furman, the Court determined that GSK met the burden of showing that consumers are likely to be confused.\u00a0 The Court found that the first factor weighed in GSK\u2019s favor, stating that there was no dispute that the BIOTENE trademark and BIOTENE droplet were both strong trademarks.\u00a0 The Court also found that the second factor favored GSK because Laclede conceded that its BIOTENE marks used in their advertising materials were identical to GSK\u2019s trademarks.\u00a0 Since the SALIVEA product line is a direct competitor to the BIOTENE product line, the Court found this factor also favored GSK.\u00a0 The Court determined that the fifth factor weighed only slightly in favor of GSK, explaining that even though only twenty reported cases of actual confusion by healthcare professionals were reported, the relatively small number of declarations revealed actual consumer confusion.\u00a0 The Court also determined that Laclede acted in bad faith because some advertisements mentioned BIOTENE more frequently than they mentioned SALIVEA and because the advertisements created the impression that SALIVEA was an improved version of BIOTENE.\u00a0 With respect to the seventh factor, the Court concluded that it favored neither GSK nor Laclede because the quality of SALIVEA would neither create confusion, nor that such confusion would harm GSK\u2019s reputation.\u00a0 Finally, the Court determined that the eighth factor favored Laclede indicating that both the ultimate consumer and healthcare professionals are sophisticated and familiar with the dental product market. \u00a0<\/p>\r\n\r\n\r\n\r\n<p>The Court ordered Laclede to refrain from using: the blue-and-red BIOTENE logo and confusingly similar variations; images of the packaging; and from advertising SALIVEA as a replacement for BIOTENE.\u00a0 Several months following the January 23, 2019 Opinion and Order, GSK and Laclede entered into a settlement agreement.\u00a0 The settlement agreement prohibits Laclede from making statements such as \u201c#1 Brand for Dry Mouth\u201d in connection with advertising and packaging its products.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>The U.S. District Court for the Southern District of New York issued its final consent judgment to the settlement agreement between GSK and Laclede, Inc. on Friday, May 24, 2019.\u00a0\u00a0By issuing its final consent judgment, the U.S. District Court for the Southern District of New York agreed to the settlement agreement between GSK and Laclede&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"gallery","meta":{"footnotes":""},"categories":[1,40],"tags":[],"class_list":["post-3412","post","type-post","status-publish","format-gallery","hentry","category-blog","category-trademarks","post_format-post-format-gallery"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0 - Omni Legal Group Blog<\/title>\n<meta name=\"description\" content=\"To know more on trade mark infringement and its repercussions. Contact Omni Legal Group at 310.276.6664 or visit www.OmniLegalGroup.com to learn more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0 - Omni Legal Group Blog\" \/>\n<meta property=\"og:description\" content=\"To know more on trade mark infringement and its repercussions. Contact Omni Legal Group at 310.276.6664 or visit www.OmniLegalGroup.com to learn more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Omni Legal Group Blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-29T17:59:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-23T09:21:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-799x1024.jpg\" \/>\n<meta name=\"author\" content=\"Omid Khalifeh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Omid Khalifeh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/\"},\"author\":{\"name\":\"Omid Khalifeh\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#\\\/schema\\\/person\\\/e88d4972c6e30001cc41817b64d35fa4\"},\"headline\":\"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0\",\"datePublished\":\"2019-05-29T17:59:41+00:00\",\"dateModified\":\"2020-10-23T09:21:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/\"},\"wordCount\":1012,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/GlaxoSmithKline_building_London_30_July_2007_cropped-799x1024.jpg\",\"articleSection\":[\"Blog\",\"Trademarks\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/\",\"url\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/\",\"name\":\"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0 - Omni Legal Group Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/GlaxoSmithKline_building_London_30_July_2007_cropped-799x1024.jpg\",\"datePublished\":\"2019-05-29T17:59:41+00:00\",\"dateModified\":\"2020-10-23T09:21:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#\\\/schema\\\/person\\\/e88d4972c6e30001cc41817b64d35fa4\"},\"description\":\"To know more on trade mark infringement and its repercussions. Contact Omni Legal Group at 310.276.6664 or visit www.OmniLegalGroup.com to learn more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/#primaryimage\",\"url\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/GlaxoSmithKline_building_London_30_July_2007_cropped.jpg\",\"contentUrl\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/GlaxoSmithKline_building_London_30_July_2007_cropped.jpg\",\"width\":1382,\"height\":1772},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/\",\"name\":\"Omni Legal Group Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/#\\\/schema\\\/person\\\/e88d4972c6e30001cc41817b64d35fa4\",\"name\":\"Omid Khalifeh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g\",\"caption\":\"Omid Khalifeh\"},\"url\":\"https:\\\/\\\/omnilegalgroup.com\\\/blog\\\/author\\\/omid-khalifeh\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0 - Omni Legal Group Blog","description":"To know more on trade mark infringement and its repercussions. Contact Omni Legal Group at 310.276.6664 or visit www.OmniLegalGroup.com to learn more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/","og_locale":"en_US","og_type":"article","og_title":"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0 - Omni Legal Group Blog","og_description":"To know more on trade mark infringement and its repercussions. Contact Omni Legal Group at 310.276.6664 or visit www.OmniLegalGroup.com to learn more.","og_url":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/","og_site_name":"Omni Legal Group Blog","article_published_time":"2019-05-29T17:59:41+00:00","article_modified_time":"2020-10-23T09:21:41+00:00","og_image":[{"url":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-799x1024.jpg","type":"","width":"","height":""}],"author":"Omid Khalifeh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Omid Khalifeh","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/#article","isPartOf":{"@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/"},"author":{"name":"Omid Khalifeh","@id":"https:\/\/omnilegalgroup.com\/blog\/#\/schema\/person\/e88d4972c6e30001cc41817b64d35fa4"},"headline":"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0","datePublished":"2019-05-29T17:59:41+00:00","dateModified":"2020-10-23T09:21:41+00:00","mainEntityOfPage":{"@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/"},"wordCount":1012,"commentCount":0,"image":{"@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/#primaryimage"},"thumbnailUrl":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-799x1024.jpg","articleSection":["Blog","Trademarks"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/","url":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/","name":"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0 - Omni Legal Group Blog","isPartOf":{"@id":"https:\/\/omnilegalgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/#primaryimage"},"image":{"@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/#primaryimage"},"thumbnailUrl":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped-799x1024.jpg","datePublished":"2019-05-29T17:59:41+00:00","dateModified":"2020-10-23T09:21:41+00:00","author":{"@id":"https:\/\/omnilegalgroup.com\/blog\/#\/schema\/person\/e88d4972c6e30001cc41817b64d35fa4"},"description":"To know more on trade mark infringement and its repercussions. Contact Omni Legal Group at 310.276.6664 or visit www.OmniLegalGroup.com to learn more.","breadcrumb":{"@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/#primaryimage","url":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped.jpg","contentUrl":"https:\/\/omnilegalgroup.com\/blog\/wp-content\/uploads\/2019\/05\/GlaxoSmithKline_building_London_30_July_2007_cropped.jpg","width":1382,"height":1772},{"@type":"BreadcrumbList","@id":"https:\/\/omnilegalgroup.com\/blog\/can-a-pharmaceutical-company-continue-making-statements-such-as-1-brand-for-dry-mouth-in-advertising-its-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/omnilegalgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Can a pharmaceutical company continue making statements such as \u201c#1 Brand for Dry Mouth\u201d in advertising its products?\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/omnilegalgroup.com\/blog\/#website","url":"https:\/\/omnilegalgroup.com\/blog\/","name":"Omni Legal Group Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/omnilegalgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/omnilegalgroup.com\/blog\/#\/schema\/person\/e88d4972c6e30001cc41817b64d35fa4","name":"Omid Khalifeh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/565923ffc8a80adddedf281a6f7f8052a83bed9b1506537aa4654cebd9b3097a?s=96&d=mm&r=g","caption":"Omid Khalifeh"},"url":"https:\/\/omnilegalgroup.com\/blog\/author\/omid-khalifeh\/"}]}},"_links":{"self":[{"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=3412"}],"version-history":[{"count":2,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3412\/revisions"}],"predecessor-version":[{"id":3778,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3412\/revisions\/3778"}],"wp:attachment":[{"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=3412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=3412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/omnilegalgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=3412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}